BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30404109)

  • 1. Pathogenesis of ANCA-Associated Pulmonary Vasculitis.
    Alba MA; Jennette JC; Falk RJ
    Semin Respir Crit Care Med; 2018 Aug; 39(4):413-424. PubMed ID: 30404109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of Pulmonary Manifestations in ANCA-Associated Vasculitis and Goodpasture Syndrome.
    Fouka E; Drakopanagiotakis F; Steiropoulos P
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis.
    Hurtado PR; Jeffs L; Nitschke J; Patel M; Sarvestani G; Cassidy J; Hissaria P; Gillis D; Peh CA
    BMC Immunol; 2008 Jul; 9():34. PubMed ID: 18625057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary granulomas in a patient with positive ANCA and history of tuberculosis: case report.
    Wong B; Tan E; McLean-Tooke A
    BMC Pulm Med; 2020 Aug; 20(1):219. PubMed ID: 32795275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary pathology in vasculitis.
    Ambrogi E; Cavazza A; Smith ML; Graziano P
    Pathologica; 2024 Apr; 116(2):93-103. PubMed ID: 38767542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolving pathogenesis of systemic vasculitis.
    Savage CO
    Clin Med (Lond); 2002; 2(5):458-64. PubMed ID: 12448596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Updates in Antineutrophil Cytoplasmic Autoantibodies (ANCA) Vasculitis.
    Jain K; Jawa P; Derebail VK; Falk RJ
    Kidney360; 2021 Apr; 2(4):763-770. PubMed ID: 34095854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual histological evidence or anti-neutrophil cytoplasmic antibody associated vasculitis.
    Martin de Frémont G; Hourseau M; Rouger M; Papo T; Goulenok T
    Rheumatology (Oxford); 2024 May; 63(6):e160-e161. PubMed ID: 38216761
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathogenesis and therapeutic interventions for ANCA-associated vasculitis.
    Nakazawa D; Masuda S; Tomaru U; Ishizu A
    Nat Rev Rheumatol; 2019 Feb; 15(2):91-101. PubMed ID: 30542206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANCA-Associated Vasculitis: Core Curriculum 2020.
    Geetha D; Jefferson JA
    Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Evolving Concepts in Treatment.
    Lynch JP; Derhovanessian A; Tazelaar H; Belperio JA
    Semin Respir Crit Care Med; 2018 Aug; 39(4):434-458. PubMed ID: 30404111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alveolar Hemorrhage in Vasculitis (Primary and Secondary).
    Nasser M; Cottin V
    Semin Respir Crit Care Med; 2018 Aug; 39(4):482-493. PubMed ID: 30404115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Pulmonary Vasculitis.
    Terrier B; Guillevin L
    Semin Respir Crit Care Med; 2018 Aug; 39(4):504-510. PubMed ID: 30404117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary vasculitis: diagnosis and treatment.
    Anaev EK; Baranova IA; Belevsky AS
    Ter Arkh; 2018 Apr; 90(3):99-106. PubMed ID: 30701864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis.
    Sebastiani M; Manfredi A; Vacchi C; Cassone G; Faverio P; Cavazza A; Sverzellati N; Salvarani C; Luppi F
    Clin Exp Rheumatol; 2020; 38 Suppl 124(2):221-231. PubMed ID: 32324122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Disease Activity at Three and Six Months After Diagnosis on Long-Term Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Gopaluni S; Flossmann O; Little MA; O'Hara P; Bekker P; Jayne D;
    Arthritis Rheumatol; 2019 May; 71(5):784-791. PubMed ID: 30418705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
    Walsh M; Merkel PA; Peh CA; Szpirt WM; Puéchal X; Fujimoto S; Hawley CM; Khalidi N; Floßmann O; Wald R; Girard LP; Levin A; Gregorini G; Harper L; Clark WF; Pagnoux C; Specks U; Smyth L; Tesar V; Ito-Ihara T; de Zoysa JR; Szczeklik W; Flores-Suárez LF; Carette S; Guillevin L; Pusey CD; Casian AL; Brezina B; Mazzetti A; McAlear CA; Broadhurst E; Reidlinger D; Mehta S; Ives N; Jayne DRW;
    N Engl J Med; 2020 Feb; 382(7):622-631. PubMed ID: 32053298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung involvement in ANCA-associated vasculitis.
    Sacoto G; Boukhlal S; Specks U; Flores-Suárez LF; Cornec D
    Presse Med; 2020 Oct; 49(3):104039. PubMed ID: 32650042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Strategies in ANCA-Associated Vasculitis.
    Emejuaiwe N
    Curr Rheumatol Rep; 2019 May; 21(7):33. PubMed ID: 31123922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary vasculitis.
    Casal A; Díaz-Garel J; Pereiro T; Toubes ME; Ricoy J; Valdés L
    J Thorac Dis; 2018 Sep; 10(9):5560-5575. PubMed ID: 30416807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.